{"id":"306","presentation":"210 - An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient","session":"SESSION 56 - ORAL: The Pharmacist is IN! LVAD, Heart, and Lung Transplant Medication Questions Answered","filename":"ISHLT 2020 Presentation 210 Oral Ribavirin RSV in LTX Carlos et al .pptx","speaker":"L. Carlos<small>, Sydney, Australia<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/306\/jpg\/ishlt2020presentation210oralribavirinrsvinltxcarlosetal\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/2f3523998def4f29c007809ff00ea7af","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]